pharma · Advanced Cancer · Non-small Cell Lung Cancer · RCUS
Arcus Biosciences
Arcus Biosciences clinical programs — 22 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3928 Point Eden Way, Hayward, California 94545, US
- Founded
- 2015
- Employees
- 655
- Programs
- 53
- Drugs
- 25
- Patents
- 30
Arcus Biosciences projects
22 ClinicalTrials.gov programs sponsored by Arcus Biosciences.
Arcus Biosciences has 22 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AB308
Arcus Biosciences
Advanced Solid Tumor
1 trial -
AB598
Arcus Biosciences
Advanced Cancer
1 trial -
AB680
Arcus Biosciences
Advanced Pancreatic Cancer
1 trial -
AB680
Arcus Biosciences
Healthy Volunteers
2 trials -
AB801
Arcus Biosciences
Cancer
1 trial -
AB801
Arcus Biosciences
Advanced Cancer
1 trial -
ARC-12
Arcus Biosciences
Multiple Myeloma, Diffuse large B cell lymphoma (DLBCL), Esophageal Cancer, Gastroesophageal Junction Adenocarcinoma, Melanoma, Advanced Solid Tumor, Gastrointestinal (GI) cancer, Hematological (heme) cancer, Gynecological (Gyn) cancer, Non-small cell lung cancer (NSCLC), Non-Hodgkin Lymphoma, Gastric Cancer, Cervical Cancer
1 trial -
ARC-20
Arcus Biosciences
Solid Tumors, Clear Cell Renal Cell Carcinoma
1 trial -
Casdatifan
Arcus Biosciences
Healthy Participants
3 trials -
Domvanalimab
Arcus Biosciences
Solid Tumor, Unspecified, Adult
1 trial -
Etrumadenant
Arcus Biosciences
Non-small Cell Lung Cancer
1 trial -
Etrumadenant
Arcus Biosciences
Non Small Cell Lung Cancer Metastatic
1 trial -
Etrumadenant
Arcus Biosciences
TNBC - Triple-Negative Breast Cancer
1 trial -
Etrumadenant
Arcus Biosciences
Healthy Participants
2 trials -
Quemliclustat
Arcus Biosciences
Healthy Participants
1 trial -
Zimberelimab
Arcus Biosciences
Head and Neck Cancer
1 trial -
Zimberelimab
Arcus Biosciences
Glioblastoma
1 trial -
[14C]-etrumadenant
Arcus Biosciences
Healthy Participants
1 trial -
casdatifan
Arcus Biosciences
Clear Cell Renal Cell Carcinoma
1 trial -
etrumadenant
Arcus Biosciences
GastroEsophageal Cancer
1 trial -
zanzalintinib
Arcus Biosciences
Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
1 trial -
zimberelimab
Arcus Biosciences
Advanced Solid Tumors
1 trial
Frequently asked questions
How many clinical projects does Arcus Biosciences have?
22 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.